Events

EIT webinar - New innovation opportunity for CCSI
APR
Wed
21
14:00 - 15:30

This was 4 years ago

Location

Online webinar

Programmes
Culture and society

On 21 April 2021 at 14:00 - 15:30 (CET), The European Institue of Innovation and Technology (EIT) will organize the EIT webinar - New innovation opportunity for CCSI. During this webinar you will find out more about EIT’s upcoming Call for Proposals to boost innovation in the Cultural & Creative Sectors and Industries and how organisations from business, higher education and research can be involved in this new Knowledge and Innovation Community (KIC).

More information on this webinar can be found on the event’s webpage.

In this news article you can find more information about this new KIC on Cultural & Creative Sectors and Industries.

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Event calendar

 

Testimonial

image of Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.